Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2011-06-14
2011-06-14
Lilling, Herbert J. (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S029000, C435S030000, C435S170000, C435S252100, C435S252900, C435S373000, C436S063000, C424S093450, C424S094600, C424S439000, C424S780000, C426S061000
Reexamination Certificate
active
07960137
ABSTRACT:
Strains ofLactobacilluswhich have been selected for their capability of reducing gastrointestinal inflammation, such as that due toHelicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated withHelicobacter pylorifor administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
REFERENCES:
patent: 5439678 (1995-08-01), Dobrogosz et al.
patent: 5458875 (1995-10-01), Casas et al.
patent: 5534253 (1996-07-01), Casas et al.
patent: 5837238 (1998-11-01), Casas et al.
patent: 5849289 (1998-12-01), Dobrogosz et al.
patent: 6051557 (2000-04-01), Drucker
patent: 6613751 (2003-09-01), Raz et al.
patent: 7485627 (2009-02-01), Raz et al.
patent: 7678553 (2010-03-01), Connolly et al.
patent: 2003/0176389 (2003-09-01), Raz et al.
patent: 2004/0241149 (2004-12-01), De Simone
patent: 2005/0180962 (2005-08-01), Raz et al.
Christensen,LactobacilliDifferentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells, J. Immunol. 168:171-178, 2002.
Ehejorn, Thesis:Presence ofLactobacillusssp. in the Human Stomach and Their Effects onHelicobacter pylori, Uppsala Universitet, Examensarbete, Jun. 2000.
Maasen, Strain-dependent induction of cytokine profiles in the gut by orally administeredLactobacillusstrains, Vaccine 18(23):2613-23, 2000.
Mahdavi,Helicobacter pyloriSabA Adhesion in Persistent Infection and Chronic Inflammation, Science: 573-578, 2002.
Mukai, Inhibition of binding ofHelicobacter pylorito the glycolipid receptors by probioticLactobacillus reuteri, FEMS Immunol. & Med. Microbiol. 32:105-110, 2002.
Sakamoto, Suppressive effect ofLactobacillusgasseri OLL 2716 (LG21) onHelicobacter pyloriinfection in humans, J. Antimicrobiol. Chemotherapy 47:709-710, 2001.
Tejada-Simon, (Abstract)Ex vivo effects oflactobacilli, streptococci, andbifidobacteriaingestion on cytokine and nitric oxide production i, J. Food. Prot. 62(2):162-9, 1999.
Thalmaker, (Abstract) Role of Tumor Necrosis Factor Alpha inHelicobacter pyloriGastritis in Tumor Necrosis Factor Receptor 1-Deficient.., Infect. Immun. 70(6):3149-55, 2002.
Connolly Eamonn
Mollstam Bo
Barber Lynn E.
Biogala AB
Lilling Herbert J.
LandOfFree
Selection and use of lactic acid bacteria for reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selection and use of lactic acid bacteria for reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selection and use of lactic acid bacteria for reducing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2661800